bioept (BIOC)表示,它允许Plus (PSTV)在其临床试验和商业中使用CNSide测试,等待监管部门的批准。Plus Therapeutics (PSTV)的股票在反...查看全文
不入流资讯2023-09-08 20:23
$Plus Therapeutics(PSTV)$ Plus Therapeutics jumps 23% premarket after obtaining a nonexclusive license and option for exclusivity for patients receiving CNS radiotherapy查看全文
牛股小红书2022-04-06 13:10
$Plus Therapeutics(PSTV)$ 表示,已扩大与Dassault Systèmes(OTCPK:DASTY)旗下公司Medidata的合作伙伴关系,以加快Rhenium-186纳米脂质体治疗复发性胶质母细胞瘤的2期临床试验的注册速度,降低临床试验成本。
该合作关系将使用Medidata的合成控制臂平台,该平台以美国食品和药物管理局认可...查看全文
薛定锷之猫2021-11-23 09:49
$Plus Therapeutics(PSTV)$ 所谓的放射性纳米疗法治复发性GBM,大概率失败?终于明白当初TOCA为啥也是找晚期复发性GBM下手了。市值2千万,真正的仙股啊。查看全文
$Plus Therapeutics(PSTV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-10-07 AccNo: 0001213900-19-019831 Size: 64 KB 网页链接
$Plus Therapeutics(PSTV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-10-03 AccNo: 0000919574-19-006196 Size: 114 KB 网页链接
$Plus Therapeutics(PSTV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-09-27 AccNo: 0001193125-19-256886 Size: 134 KB 网页链接
$Plus Therapeutics(PSTV)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2019-09-24 AccNo: 0001564590-19-035317 Size: 604 KB 网页链接
$Plus Therapeutics(PSTV)$ 8-K - Current report Filed: 2019-09-23 AccNo: 0001564590-19-035222 Size: 57 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Plus Therapeutics(PSTV)$ EFFECT - Notice of Effectiveness Filed: 2019-09-23 AccNo: 9999999995-19-002148 Size: 1 KB 网页链接
$Plus Therapeutics(PSTV)$ 8-K - Current report Filed: 2019-09-23 AccNo: 0001564590-19-035159 Size: 31 KBItem 8.01: Other Events 网页链接
$Plus Therapeutics(PSTV)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-09-16 AccNo: 0001564590-19-034798 Size: 1 MB 网页链接
$Plus Therapeutics(PSTV)$ FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2019-09-16 AccNo: 0001564590-19-034805 Size: 1 MB 网页链接
$Plus Therapeutics(PSTV)$ 8-K - Current report Filed: 2019-09-10 AccNo: 0001564590-19-034402 Size: 13 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接